The firm will deliver SGT-212 to patients' brains and intravenously to try to restore frataxin levels and diminish ...
Derry Journal on MSNOpinion
‘We deserve the same chance as others': Derry teen with Friedreich’s ataxia speaks out on lack of access to vital medication
A 17-year-old Derry girl, who was diagnosed with Friedreich’s ataxia at age seven, has outlined how a medication that can ...
Please provide your email address to receive an email when new articles are posted on . Vatiquinone inhibits 15-Lipoxygenase, which regulates the pathways that Friedreich’s ataxia disrupts. PTC ...
Several months after forging a fresh path forward for its troubled Friedreich ataxia (FA) drug vatiquinone, PTC Therapeutics is back with some much-needed positive data. The candidate passed muster by ...
Troriluzole 200 mg dosed orally, once daily, in patients with SCA met the study's primary endpoint on the change from baseline in the modified functional Scale for the Assessment and Rating of Ataxia ...
WARREN, N.J., Oct. 8, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) provided today several positive updates on the vatiquinone Friedreich ataxia (FA) program. The pre-specified endpoint ...
Bill Nye The Science Guy Lends His Unique Voice to Raise Awareness of Rare Neurodegenerative Disease
MINNEAPOLIS--(BUSINESS WIRE)--Bill Nye, who has helped make science a part of pop culture for a generation of adults and children, is now using his acclaimed platform to educate people about Ataxia, a ...
The U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) on Tuesday related to PTC Therapeutics, Inc.‘s PTCT New Drug Application (NDA) for vatiquinone for Friedreich’s ...
Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.
Home-based high-intensity aerobic training was associated with greater improvement in cerebellar ataxia symptoms, fitness, and fatigue compared with guidelines-recommended balance training in a ...
- Following FDA pre-NDA feedback, submission on track for December 2024 - WARREN, N.J., Oct. 8, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (PTCT) provided today several positive updates on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results